FRANKLIN LAKES, N.J., Oct. 3, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Tom Polen will add the responsibility of chief operating officer of BD, in addition to his current role as president. Polen continues to report Vincent A. Forlenza, chairman and CEO. As president and chief operating officer, Polen... Read more
FRANKLIN LAKES, N.J., Sept. 7, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the sale of its Advanced Bioprocessing business to Thermo Fisher Scientific: “The sale of our Advanced Bioprocessing business will create greater focus for our Life Sciences segment where BD... Read more
FRANKLIN LAKES, N.J., June 1, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: Jefferies 2018 Global Healthcare ConferenceJune 8, 201810:00 a.m. EDT Goldman Sachs 38th Annual Global Healthcare ConferenceJune 13, 20188:40 a.m. EDT Live webcasts... Read more
FRANKLIN LAKES, N.J., April 27, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced three executive appointments to the positions of segment president. Alberto Mas, 56, has been named president of the Medical Segment for BD, effective May 29, reporting to Tom Polen, president of BD.... Read more
FRANKLIN LAKES, N.J., April 26, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform... Read more
FRANKLIN LAKES, N.J., April 19, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance. The new molecular, microbiology and software solutions will be showcased... Read more
FRANKLIN LAKES, N.J., March 22, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is updating the instructions for use of certain BD Vacutainer® tubes as part of its quality process to ensure that customers understand the appropriate uses of these products. Since BD became... Read more
FRANKLIN LAKES, N.J., March 19, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has signed a definitive agreement to divest its remaining, minority stake in Vyaire Medical to funds managed by Apax Partners. According to the terms of the agreement, BD will receive $435... Read more
19 March 2018 Chicago and London, March 19, 2018 – Funds advised by Apax Partners (“the Apax Funds”) today announced they have entered into a definitive agreement to purchase from BD (Becton, Dickinson and Company) its remaining ownership interest in Vyaire Medical, Inc., a global leader in respiratory care. Upon completion of the transaction, which... Read more
FRANKLIN LAKES, N.J., March 8, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 14, 2018, at 1:35 p.m. ET. A live webcast of BD’s presentations can be accessed from the BD corporate website... Read more